Preeclampsia is a pregnancy-specific disorder, and it is a leading cause of maternal and
perinatal morbidity and mortality. The application of pharmacogenetics to antihypertensive …

Preeclampsia is a progressive, multisystem pregnancy disorder. According to the time of
onset or delivery, preeclampsia has been subclassified into early-onset (< 34 weeks) and …

During healthy pregnancy, the placenta develops to allow for exchange of nutrients and
oxygen between the mother and the fetus. However, placental dysregulation can lead to …

Importance As venous thromboembolism (VTE) remains one of the leading causes of
maternal mortality, identifying women at increased risk of VTE is of great importance …

Autoantibodies directed against complement component C1q are commonly associated with
autoimmune diseases, especially systemic lupus erythematosus. Importantly, these anti-C1q …

Introduction Maternal health is a critical aspect of public health that affects the wellbeing of
both mothers and infants. Despite medical advancements, maternal mortality rates remain …

Preeclampsia (PE) is a pregnancy-specific disorder affecting 4–10% of all expectant women.
It greatly increases the risk of maternal and foetal death. Although the main symptoms …

Preeclampsia is more common in nulliparous women, their first pregnancies with a new
partner in multiparous women, pregnant women with short duration of cohabitation, and in …

The factors controlling linear growth and weight gain in the human fetus and newborn infant
are poorly understood. We review here the changes in linear growth, weight gain, lean body …

Graphically encoded hydrogel microparticle (HMP)-based bioassay is a diagnostic tool
characterized by exceptional multiplex detectability and robust sensitivity and specificity …